Internship - Consumer Marketing jobs in United States
cer-icon
Apply on Employer Site
company-logo

Novo Nordisk · 4 hours ago

Internship - Consumer Marketing

Novo Nordisk is a global pharmaceutical company focused on creating human-centered experiences in healthcare. The Consumer Marketing intern will work closely with experienced professionals, gaining hands-on experience while contributing to consumer marketing projects within the obesity business unit.

BiotechnologyHealth CareMedicalPharmaceutical
check
Growth Opportunities
badNo H1Bnote

Responsibilities

Gain consumer marketing experience with the Consumer GLP-1 brand MASH team, working within the obesity business unit
Lead hands-on projects for consumer marketing projects including digital social media, websites and digital display ads
Learn about media strategy across disease awareness and branded campaigns with a specific focus on the MASH indication

Qualification

Consumer MarketingMicrosoft OfficeProject ManagementInterpersonal CommunicationSelf-Motivation

Required

Must be a current student enrolled or recently graduated (graduation date no earlier than April 2026) at/from an accredited college or university pursuing at least a bachelor's degree
Strong academic record with a preferred cumulative GPA of 3.0 or higher
Conscientious self-starter with good organizational skills, project management skills and attention to detail
Ability to balance multiple projects and priorities, must be able to multi-task
Strong interpersonal communication and ability to collaborate with teams; must effectively operate independently, across functional lines, and with internal customers
Demonstrated personal initiative, self-motivation, flexibility, adaptability and willingness to learn
Proficient in Microsoft Office Tools including Word, Excel, PowerPoint, etc

Preferred

A completed or in progress undergraduate degree in Business Administration, Marketing or a related discipline preferred

Company

Novo Nordisk

company-logo
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.

Funding

Current Stage
Public Company
Total Funding
$22M
2018-12-05Post Ipo Equity· $22M
1981-07-09IPO

Leadership Team

leader-logo
Lars Fruergaard Jørgensen
President and CEO
linkedin
leader-logo
Lars Sorensen
President & CEO
Company data provided by crunchbase